Phenotypic variability in TRPV4-associated neuropathies and neuronopathies: a case series

Cover Page

Cite item

Full Text

Abstract

TRPV4‑associated neuromuscular diseases represent a clinical spectrum of neuropathies and motor neuron disorders. To date, 3 phenotypic forms are distinguished. There are Charcot–Marie–Tooth disease type 2C, distal hereditary motor neuropathy type 8 (DHMN8), scapulo‑peroneal spinal muscular atrophy (SPSMA). Here we report 3 families with DNMN8 and one family with SPSMA. In all cases, DNA‑analysis revealed single nucleotide variants in the TRPV4 gene previously reported as pathogenic. In 3 probands, a combination of signs of both motor and motor‑sensory neuropathies led to difficulties in the establishment of the clinical diagnosis. Patients had mild sensory disturbances in the feet, but in all of these cases nerve conduction study revealed normal sensory nerve action potentials. Considering the prevailing signs of motor neuropathy, these patients were diagnosed with DNMN8. Clinical signs of sensory disturbances are regarded as not  contradicting  the  diagnosis,  since  they  can  be  observed  in  various  forms  of  distal  motor  neuropathies. The clinical features of SPSMA in one patient corresponded to those previously described in the literature. The involvement of the shoulder girdle muscles and the peroneal muscles and neurogenic changes in needle electromyography allow suspecting SPSMA clinically. A distinctive features of TRPV4‑associated neuromuscular diseases are the vocal cords paresis, sensorineural hearing loss and respiratory failure, however they are not obligatory according to our clinical reports.

About the authors

A. F. Murtazina

N. P. Bochkov Medical Genetic Research Center

Author for correspondence.
Email: fake@neicon.ru

Aysylu Fanzirovna Murtazina

1 Moskvorechye St., Moscow 115522

Russian Federation

P. N. Tsabay

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

G. E. Rudenskaya

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

L. A. Bessonova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

F. M. Bostanova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

D. M. Guseva

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

I. V. Sharkova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

O. A. Shchagina

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

A. A. Orlova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

O. P. Ryzhkova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

T. V. Markova

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

A. S. Kuchina

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

S. S. Nikitin

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

E. L. Dadali

N. P. Bochkov Medical Genetic Research Center

Email: fake@neicon.ru

1 Moskvorechye St., Moscow 115522

Russian Federation

References

  1. Auer-Grumbach M., Olschewski A., Papic L. et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 2010;42(2): 160–4. doi: 10.1038/ng.508
  2. Zimon M., Baets J., Auer-Grumbach M. et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 2010;133(Pt 6):1798–809. doi: 10.1093/brain/awq109
  3. Fiorillo C., Moro F., Brisca G. et al. TRPV4 mutations in children with congenital distal spinal muscular atrophy. Neurogenetics 2012;13(3):195–203. doi: 10.1007/s10048-012-0328-7
  4. Chen D.H., Sul Y., Weiss M. et al. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. Neurology 2010;75(22):1968–75. doi: 10.1212/WNL.0b013e3181ffe4bb
  5. Aharoni S., Harlalka G., Offiah A. et al. Striking phenotypic variability in familial TRPV4-axonal neuropathy spectrum disorder. Am J Med Genet A 2011;155A(12):3153–6. doi: 10.1002/ajmg.a.34327
  6. Berciano J., Baets J., Gallardo E. et al. Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. J Neurol 2011;258(8):1413–21. doi: 10.1007/s00415-011-5947-7
  7. Koutsis G., Lynch D., Manole A. et al. Charco–Marie–Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation. J Neurol 2015;262(8):1972–5. doi: 10.1007/s00415-015-7800-x
  8. Vill K., Kuhn M., Glaser D. et al. Long-term observations in an affected family with neurogenic scapuloperoneal syndrome caused by mutation R269C in the TRPV4 gene. Neuropediatrics 2015;46(4):282–6. doi: 10.1055/s-0035-1554100
  9. Jedrzejowska M., Debek E., Kowalczyk B. et al. The remarkable phenotypic variability of the p.Arg269HiS variant in the TRPV4 gene. Muscle Nerve 2019;59(1):129–33. doi: 10.1002/mus.26346
  10. Garcia-Elias A., Lorenzo I.M., Vicente R. et al. IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli viaa calmodulin-binding site. J Biol Chem 2008;283(46):31284–8. doi: 10.1074/jbc.C800184200
  11. Kottgen M., Buchholz B., Garcia-Gonzalez M.A. et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 2008;182(3):437–47. doi: 10.1083/jcb.200805124
  12. Donate-Macian P., Jungfleisch J., Perez-Vilaro G. et al. The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity. Nat Commun 2018;9(1):2307. doi: 10.1038/s41467-018-04776-7
  13. Arniges M., Fernandez-Fernandez J.M., Albrecht N. et al. Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking. J Biol Chem 2006;281(3):1580–6. doi: 10.1074/jbc.M511456200
  14. Takahashi N., Hamada-Nakahara S., Itoh Y. et al. TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P(2). Nat Commun 2014;5:4994. doi: 10.1038/ncomms5994
  15. Strotmann R., Schultz G., Plant T.D. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site. J Biol Chem 2003;278(29):26541–9. doi: 10.1074/jbc.M302590200
  16. Stenson P.D., Ball E.V., Mort M. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21(6):577–81. doi: 10.1002/humu.10212
  17. Deng H.X., Klein C.J., Yan J. et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010;42(2):165–9. doi: 10.1038/ng.509
  18. Landoure G., Zdebik A.A., Martinez T.L. et al. Mutations in TRPV4 cause Charcot–Marie–Tooth disease type 2C. Nat Genet 2010;42(2):170–4. doi: 10.1038/ng.512
  19. Fecto F., Shi Y., Huda R. et al. Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. J Biol Chem 2011;286(19):17281–91. doi: 10.1074/jbc.M111.237685
  20. Klein C.J., Shi Y., Fecto F. et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot–Marie–Tooth neuropathies. Neurology 2011;76(10):887–94. doi: 10.1212/WNL.0b013e31820f2de3
  21. Sullivan J.M., Zimanyi C.M., Aisenberg W. et al. Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy. Neurol Genet 2015;1(4):e29. doi: 10.1212/NXG.0000000000000029
  22. Taga A., Peyton M.A., Goretzki B. et al. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function. Ann Clin Transl Neurol 2022;9(3):375–91. doi: 10.1002/acn3.51523
  23. Cho T.J., Matsumoto K., Fano V. et al. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients. Am J Med Genet A 2012;158A(4):795–802. doi: 10.1002/ajmg.a.35268
  24. Fawcett K.A., Murphy S.M., Polke J.M. et al. Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. J Neurol Neurosurg Psychiatry 2012;83(12):1204–9. doi: 10.1136/jnnp-2012-303055
  25. Drew A.P., Zhu D., Kidambi A. et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genomic Med 2015;3(2):143–54. doi: 10.1002/mgg3.126
  26. Uchoa Cavalcanti E.B., Santos S.C.L., Martins C.E.S. et al. Char-cot-Marie-Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center. J Peripher Nerv Syst 2021;26(3):290–7. doi: 10.1111/jns.12458
  27. Volodarsky M., Kerkhof J., Stuart A. et al. Comprehensive genetic sequence and copy number analysis for Charcot–Marie–Tooth disease in a Canadian cohort of 2517 patients. J Med Genet 2021;58(4):284–8. doi: 10.1136/jmedgenet-2019-106641
  28. Dai J., Kim O.H., Cho T.J. et al. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family. J Med Genet 2010;47(10):704–9. doi: 10.1136/jmg.2009.075358
  29. Markova T.V., Kenis V.M., Melchenko E.V. et al. Clinical and genetic characteristics of TRPV4-associated skeletal dysplasias in Russian patients. Meditsinskaya genetika = Medical Genetics 2022;21(4):25–37. (In Russ.). doi: 10.25557/2073-7998.2022.04.25-37
  30. Inada H., Procko E., Sotomayor M. et al. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel. Biochemistry 2012;51(31):6195–206. doi: 10.1021/bi300279b
  31. McCray B.A., Diehl E., Sullivan J.M. et al. Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension. Nat Commun 2021;12(1):1444. doi: 10.1038/s41467-021-21699-y
  32. Dyck P.J., Litchy W.J., Minnerath S. et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35(5):608–15. doi: 10.1002/ana.410350515
  33. Deng S., Feely S.M.E., Shi Y. et al. Incidence and clinical features of TRPV4-linked axonal neuropathies in a USA cohort of Char-cot–Marie–Tooth disease type 2. Neuromolecular Med 2020;22(1):68–72. doi: 10.1007/s12017-019-08564-4
  34. Fleury P., Hageman G. A dominantly inherited lower motor neuron disorder presenting at birth with associated arthrogryposis. J Neurol Neurosurg Psychiatry 1985;48(10):1037–48. doi: 10.1136/jnnp.48.10.1037
  35. Van der Vleuten A.J., van Ravenswaaij-Arts C.M., Frijns C.J. et al. Localisation of the gene for a dominant congenital spinal muscular atrophy predominantly affecting the lower limbs to chromosome 12q23–q24. Eur J Hum Genet 1998;6(4):376–82. doi: 10.1038/sj.ejhg.5200229
  36. Echaniz-Laguna A., Dubourg O., Carlier P. et al. Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy. Neurology 2014;82(21):1919–26. doi: 10.1212/WNL.0000000000000450
  37. Rossor A.M., Kalmar B., Greensmith L. et al. The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry 2012;83(1): 6–14. doi: 10.1136/jnnp-2011-300952
  38. DeLong R., Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch Neurol 1992;49(9):905–8. doi: 10.1001/archneur.1992.00530330027010
  39. McEntagart M. TRPV4 axonal neuropathy spectrum disorder. J Clin Neurosci 2012;19(7):927–33. doi: 10.1016/j.jocn.2011.12.003
  40. Biasini F., Portaro S., Mazzeo A. et al. TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature. Neuromuscul Disord 2016;26(4–5):312–5. doi: 10.1016/j.nmd.2016.02.010
  41. Landoure G., Sullivan J.M., Johnson J.O. et al. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology 2012;79(2):192–4. doi: 10.1212/WNL.0b013e31825f04b2
  42. Unger S., Lausch E., Stanzial F. et al. Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy? Am J Med Genet A 2011;155A(11):2860–4. doi: 10.1002/ajmg.a.34268
  43. Faye E., Modaff P., Pauli R. et al. Combined phenotypes of spondylometaphyseal dysplasia–Kozlowski type and Charcot–Marie– Tooth disease type 2C secondary to a TRPV4 pathogenic variant. Mol Syndromol 2019;10(3):154–60. doi: 10.1159/000495778
  44. Murtazina A.F., Shchagina O.A., Nikitin S.S. et al. Current view on phenotypic and genetic features of autosomal recessive inherited peripheral neuropathies. Annaly klinicheskoy i eksperimentalnoy nevrologii = Annals of Clinical and Experimental Neurology 2019;13(1):55–69. (In Russ.). doi: 10.25692/ACEN.2019.1.7

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Murtazina A.F., Tsabay P.N., Rudenskaya G.E., Bessonova L.A., Bostanova F.M., Guseva D.M., Sharkova I.V., Shchagina O.A., Orlova A.A., Ryzhkova O.P., Markova T.V., Kuchina A.S., Nikitin S.S., Dadali E.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 85909 от  25.08.2023.